back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-02-02 12:57 Tx date 2024-01-29 |
$LABS
MediPharm Labs Corp. |
Strachan, Keith
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+29,043 vol |
2,050,552 | |
| Filed 2024-02-02 12:57 Tx date 2024-01-29 |
$LABS
MediPharm Labs Corp. |
Strachan, Keith
4 - Director of Issuer
Direct Ownership
|
Restricted Stock Units
57 - Exercise of rights
|
-62,500 vol |
2,364,277 | |
| Filed 2024-02-02 12:53 Tx date 2024-01-29 |
$LABS
MediPharm Labs Corp. |
Pidduck, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+753,134 vol |
12,578,259 | |
| Filed 2024-02-02 12:52 Tx date 2024-01-29 |
$LABS
MediPharm Labs Corp. |
Pidduck, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Units
57 - Exercise of rights
|
-1,620,690 vol |
8,524,403 | |
| Filed 2024-02-01 12:53 Tx date 2024-01-29 |
$LABS
MediPharm Labs Corp. |
Hunter, Gregory Edison
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+40,661 vol |
852,911 | |
| Filed 2024-02-01 12:52 Tx date 2024-01-29 |
$LABS
MediPharm Labs Corp. |
Hunter, Gregory Edison
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Units
57 - Exercise of rights
|
-87,500 vol |
1,903,000 | |
| Filed 2024-01-10 15:47 Tx date 2023-12-22 |
$LABS
MediPharm Labs Corp. |
Bumby, Michael Scott
4 - Director of Issuer
Direct Ownership
|
Restricted Stock Units
46 - Compensation for services
|
+384,615 vol |
384,615 | |
| Filed 2024-01-10 15:44 Tx date 2023-04-01 |
$LABS
MediPharm Labs Corp. |
Bumby, Michael Scott
4 - Director of Issuer
Direct Ownership
|
Restricted Stock Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-01-05 17:18 Tx date 2024-01-02 |
$LABS
MediPharm Labs Corp. |
Strachan, Keith
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+75,513 vol |
2,021,509 | |
| Filed 2024-01-05 17:18 Tx date 2024-01-02 |
$LABS
MediPharm Labs Corp. |
Strachan, Keith
4 - Director of Issuer
Direct Ownership
|
Restricted Stock Units
57 - Exercise of rights
|
-162,500 vol |
2,426,777 | |
| Filed 2024-01-05 16:31 Tx date 2023-12-22 |
$LABS
MediPharm Labs Corp. |
Potts, Shelley
4 - Director of Issuer
Direct Ownership
|
Restricted Stock Units
56 - Grant of rights
|
+346,154 vol |
346,154 | |
| Filed 2024-01-05 16:31 Tx date 2020-06-22 |
$LABS
MediPharm Labs Corp. |
Potts, Shelley
4 - Director of Issuer
Direct Ownership
|
Restricted Stock Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-12-28 17:20 Tx date 2023-12-22 |
$LABS
MediPharm Labs Corp. |
Taves, Christopher David
4 - Director of Issuer
Direct Ownership
|
Restricted Stock Units
46 - Compensation for services
|
$55,000
+846,154 vol $0.065 each |
846,154 | |
| Filed 2023-12-28 17:10 Tx date 2020-07-13 |
$LABS
MediPharm Labs Corp. |
Taves, Christopher David
4 - Director of Issuer
Direct Ownership
|
Restricted Stock Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-12-27 21:33 Tx date 2023-12-22 |
$LABS
MediPharm Labs Corp. |
Strachan, Keith
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+192,333 vol |
1,945,996 | |
| Filed 2023-12-27 21:32 Tx date 2023-12-22 |
$LABS
MediPharm Labs Corp. |
Strachan, Keith
4 - Director of Issuer
Direct Ownership
|
Restricted Stock Units
57 - Exercise of rights
|
-409,220 vol |
2,589,277 | |
| Filed 2023-12-27 21:30 Tx date 2023-12-22 |
$LABS
MediPharm Labs Corp. |
Strachan, Keith
4 - Director of Issuer
Direct Ownership
|
Restricted Stock Units
56 - Grant of rights
|
+1,940,308 vol |
2,998,497 | |
| Filed 2023-12-27 21:29 Tx date 2023-12-22 |
$LABS
MediPharm Labs Corp. |
Strachan, Keith
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+1,414,945 vol |
4,419,555 | |
| Filed 2023-12-27 21:26 Tx date 2023-12-22 |
$LABS
MediPharm Labs Corp. |
Hunter, Gregory Edison
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+187,333 vol |
812,250 | |
| Filed 2023-12-27 21:25 Tx date 2023-12-22 |
$LABS
MediPharm Labs Corp. |
Hunter, Gregory Edison
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Units
57 - Exercise of rights
|
-389,581 vol |
1,990,500 | |
| Filed 2023-12-27 21:24 Tx date 2023-12-22 |
$LABS
MediPharm Labs Corp. |
Hunter, Gregory Edison
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Units
56 - Grant of rights
|
+1,894,000 vol |
2,380,081 | |
| Filed 2023-12-27 21:23 Tx date 2023-12-22 |
$LABS
MediPharm Labs Corp. |
Hunter, Gregory Edison
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+1,381,098 vol |
5,230,389 | |
| Filed 2023-12-27 21:18 Tx date 2023-12-22 |
$LABS
MediPharm Labs Corp. |
Pidduck, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+758,883 vol |
11,825,125 | |
| Filed 2023-12-27 21:18 Tx date 2023-12-22 |
$LABS
MediPharm Labs Corp. |
Pidduck, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Units
57 - Exercise of rights
|
-1,614,645 vol |
10,145,093 | |
| Filed 2023-12-27 21:17 Tx date 2023-12-22 |
$LABS
MediPharm Labs Corp. |
Pidduck, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Units
56 - Grant of rights
|
+6,869,230 vol |
11,759,738 | |
| Filed 2023-12-27 21:16 Tx date 2023-12-22 |
$LABS
MediPharm Labs Corp. |
Pidduck, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+4,390,110 vol |
10,398,583 | |
| Filed 2023-12-27 19:41 Tx date 2023-12-22 |
$LABS
MediPharm Labs Corp. |
Halyk, Christopher John
4 - Director of Issuer
Direct Ownership
|
Restricted Stock Units
56 - Grant of rights
|
+384,615 vol |
384,615 | |
| Filed 2023-12-27 19:40 Tx date 2020-08-04 |
$LABS
MediPharm Labs Corp. |
Halyk, Christopher John
4 - Director of Issuer
Direct Ownership
|
Restricted Stock Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-10-20 14:17 Tx date 2023-10-19 |
$LABS
MediPharm Labs Corp. |
Pidduck, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+1,655,172 vol |
11,066,242 | |
| Filed 2023-10-20 14:16 Tx date 2023-10-19 |
$LABS
MediPharm Labs Corp. |
Pidduck, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Units
57 - Exercise of rights
|
-1,655,172 vol |
4,890,508 | |
| Filed 2023-08-23 09:35 Tx date 2023-08-18 |
$LABS
MediPharm Labs Corp. |
Hunter, Gregory Edison
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Units
57 - Exercise of rights
|
$-6,562.50
-87,500 vol $0.075 each |
486,081 | |
| Filed 2023-08-23 09:34 Tx date 2023-08-18 |
$LABS
MediPharm Labs Corp. |
Hunter, Gregory Edison
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$6,562
+87,500 vol $0.075 each |
624,917 | |
| Filed 2023-08-23 09:23 Tx date 2023-08-18 |
$LABS
MediPharm Labs Corp. |
Strachan, Keith
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-10,463.175
-139,509 vol $0.075 each |
1,753,663 | |
| Filed 2023-08-23 09:22 Tx date 2023-08-18 |
$LABS
MediPharm Labs Corp. |
Strachan, Keith
4 - Director of Issuer
Direct Ownership
|
Restricted Stock Units
57 - Exercise of rights
|
$-16,875
-225,000 vol $0.075 each |
1,058,189 | |
| Filed 2023-08-23 09:22 Tx date 2023-08-18 |
$LABS
MediPharm Labs Corp. |
Strachan, Keith
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$16,875
+225,000 vol $0.075 each |
1,893,172 | |
| Filed 2023-08-23 09:00 Tx date 2023-08-18 |
$LABS
MediPharm Labs Corp. |
Pidduck, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Units
57 - Exercise of rights
|
$-121,551.675
-1,620,689 vol $0.075 each |
6,545,680 | |
| Filed 2023-08-23 08:59 Tx date 2023-08-18 |
$LABS
MediPharm Labs Corp. |
Pidduck, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$121,551
+1,620,689 vol $0.075 each |
9,411,070 | |
| Filed 2023-07-06 17:56 Tx date 2023-05-18 |
$LABS
MediPharm Labs Corp. |
Strachan, Keith
4 - Director of Issuer
Direct Ownership
|
Restricted Stock Units
57 - Exercise of rights
|
$-6,821.55
-90,954 vol $0.075 each |
1,692,409 | |
| Filed 2023-07-06 17:55 Tx date 2023-05-18 |
$LABS
MediPharm Labs Corp. |
Strachan, Keith
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$68,215
+90,954 vol $0.75 each |
1,408,468 | |
| Filed 2023-07-06 17:55 Tx date 2022-09-15 |
$LABS
MediPharm Labs Corp. |
Strachan, Keith
4 - Director of Issuer
Direct Ownership
|
Restricted Stock Units
57 - Exercise of rights
|
$-2,134.05
-28,454 vol $0.075 each |
314,923 | |
| Filed 2023-07-06 17:54 Tx date 2022-09-15 |
$LABS
MediPharm Labs Corp. |
Strachan, Keith
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$2,134
+28,454 vol $0.075 each |
1,317,514 | |
| Filed 2023-07-06 17:53 Tx date 2022-05-17 |
$LABS
MediPharm Labs Corp. |
Strachan, Keith
4 - Director of Issuer
Direct Ownership
|
Restricted Stock Units
57 - Exercise of rights
|
$-2,560.77
-28,453 vol $0.09 each |
405,877 | |
| Filed 2023-07-06 17:51 Tx date 2022-05-17 |
$LABS
MediPharm Labs Corp. |
Strachan, Keith
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$2,560
+28,453 vol $0.09 each |
1,226,560 | |
| Filed 2023-07-06 17:50 Tx date 2021-09-15 |
$LABS
MediPharm Labs Corp. |
Strachan, Keith
4 - Director of Issuer
Direct Ownership
|
Restricted Stock Units
57 - Exercise of rights
|
$-8,874.8026
-28,454 vol $0.3119 each |
184,330 | |
| Filed 2023-07-06 17:50 Tx date 2021-09-15 |
$LABS
MediPharm Labs Corp. |
Strachan, Keith
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$8,874
+28,454 vol $0.3119 each |
1,198,107 | |
| Filed 2023-07-06 17:48 Tx date 2022-08-18 |
$LABS
MediPharm Labs Corp. |
Strachan, Keith
4 - Director of Issuer
Direct Ownership
|
Restricted Stock Units
57 - Exercise of rights
|
$-4,062.50
-62,500 vol $0.065 each |
343,377 | |
| Filed 2023-07-06 17:47 Tx date 2022-08-18 |
$LABS
MediPharm Labs Corp. |
Strachan, Keith
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$4,062
+62,500 vol $0.065 each |
1,289,060 | |
| Filed 2023-07-06 17:45 Tx date 2021-05-19 |
$LABS
MediPharm Labs Corp. |
Strachan, Keith
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$11,483
+28,453 vol $0.4036 each |
1,169,653 | |
| Filed 2023-07-06 17:45 Tx date 2021-05-19 |
$LABS
MediPharm Labs Corp. |
Strachan, Keith
4 - Director of Issuer
Direct Ownership
|
Restricted Stock Units
57 - Exercise of rights
|
$-11,483.6308
-28,453 vol $0.4036 each |
212,784 | |
| Filed 2023-07-06 17:44 Tx date 2021-05-19 |
$LABS
MediPharm Labs Corp. |
Strachan, Keith
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+28,453 vol |
||
| Filed 2023-06-30 19:08 Tx date 2022-05-19 |
$LABS
MediPharm Labs Corp. |
Strachan, Keith
4 - Director of Issuer
Direct Ownership
|
Restricted Stock Units
57 - Exercise of rights
|
$-4,687.50
-62,500 vol $0.075 each |
||
| Filed 2023-06-30 19:07 Tx date 2022-05-19 |
$LABS
MediPharm Labs Corp. |
Strachan, Keith
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$4,687
+62,500 vol $0.075 each |
||
| Filed 2023-06-30 19:03 Tx date 2021-05-19 |
$LABS
MediPharm Labs Corp. |
Strachan, Keith
4 - Director of Issuer
Direct Ownership
|
Restricted Stock Units
57 - Exercise of rights
|
$-78,160.545
-192,989 vol $0.405 each |
||
| Filed 2023-06-30 19:02 Tx date 2021-05-19 |
$LABS
MediPharm Labs Corp. |
Strachan, Keith
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+192,989 vol |
||
| Filed 2023-06-30 19:16 Tx date 2023-06-22 |
$LABS
MediPharm Labs Corp. |
Strachan, Keith
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-15,615.84
-260,264 vol $0.06 each |
1,656,393 | |
| Filed 2023-06-30 19:15 Tx date 2023-06-22 |
$LABS
MediPharm Labs Corp. |
Strachan, Keith
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$24,553
+409,220 vol $0.06 each |
1,916,657 | |
| Filed 2023-06-30 19:14 Tx date 2023-06-22 |
$LABS
MediPharm Labs Corp. |
Strachan, Keith
4 - Director of Issuer
Direct Ownership
|
Restricted Stock Units
57 - Exercise of rights
|
$-24,553.20
-409,220 vol $0.06 each |
1,294,968 | |
| Filed 2023-06-30 19:12 Tx date 2022-12-22 |
$LABS
MediPharm Labs Corp. |
Strachan, Keith
4 - Director of Issuer
Direct Ownership
|
Restricted Stock Units
56 - Grant of rights
|
+818,440 vol |
1,704,188 | |
| Filed 2023-06-30 19:11 Tx date 2022-12-22 |
$LABS
MediPharm Labs Corp. |
Strachan, Keith
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$15,345
+204,610 vol $0.075 each |
3,004,610 | |
| Filed 2023-06-30 19:10 Tx date 2022-10-06 |
$LABS
MediPharm Labs Corp. |
Strachan, Keith
4 - Director of Issuer
Direct Ownership
|
Restricted Stock Units
56 - Grant of rights
|
+650,000 vol |
885,748 | |
| Filed 2023-06-30 19:09 Tx date 2022-10-06 |
$LABS
MediPharm Labs Corp. |
Strachan, Keith
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$58,500
+650,000 vol $0.09 each |
2,800,000 | |
| Filed 2023-06-30 19:08 Tx date 2022-05-19 |
$LABS
MediPharm Labs Corp. |
Strachan, Keith
4 - Director of Issuer
Direct Ownership
|
Restricted Stock Units
57 - Exercise of rights
|
$-4,687.50
-62,500 vol $0.075 each |
235,748 | |
| Filed 2023-06-30 19:07 Tx date 2022-05-19 |
$LABS
MediPharm Labs Corp. |
Strachan, Keith
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$4,687
+62,500 vol $0.075 each |
1,396,689 | |
| Filed 2023-06-30 19:05 Tx date 2022-01-27 |
$LABS
MediPharm Labs Corp. |
Strachan, Keith
4 - Director of Issuer
Direct Ownership
|
Restricted Stock Units
56 - Grant of rights
|
+250,000 vol |
298,248 | |
| Filed 2023-06-30 19:04 Tx date 2022-01-27 |
$LABS
MediPharm Labs Corp. |
Strachan, Keith
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$292,500
+1,500,000 vol $0.195 each |
2,150,000 | |
| Filed 2023-06-30 19:03 Tx date 2021-05-19 |
$LABS
MediPharm Labs Corp. |
Strachan, Keith
4 - Director of Issuer
Direct Ownership
|
Restricted Stock Units
57 - Exercise of rights
|
$-78,160.545
-192,989 vol $0.405 each |
48,248 | |
| Filed 2023-06-30 19:02 Tx date 2021-05-19 |
$LABS
MediPharm Labs Corp. |
Strachan, Keith
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+192,989 vol |
1,334,189 | |
| Filed 2023-06-30 19:01 Tx date 2021-03-15 |
$LABS
MediPharm Labs Corp. |
Strachan, Keith
4 - Director of Issuer
Direct Ownership
|
Restricted Stock Units
56 - Grant of rights
|
+241,237 vol |
241,237 | |
| Filed 2023-06-30 19:00 Tx date 2018-10-01 |
$LABS
MediPharm Labs Corp. |
Strachan, Keith
4 - Director of Issuer
Direct Ownership
|
Restricted Stock Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-06-30 19:00 Tx date 2021-03-15 |
$LABS
MediPharm Labs Corp. |
Strachan, Keith
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$24,250
+50,000 vol $0.485 each |
650,000 | |
| Filed 2023-06-27 13:03 Tx date 2023-06-22 |
$LABS
MediPharm Labs Corp. |
Hunter, Gregory Edison
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-12,675.42
-211,257 vol $0.06 each |
537,417 | |
| Filed 2023-06-27 13:02 Tx date 2023-06-22 |
$LABS
MediPharm Labs Corp. |
Hunter, Gregory Edison
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Units
57 - Exercise of rights
|
$-23,914.92
-398,582 vol $0.06 each |
573,581 | |
| Filed 2023-06-27 13:01 Tx date 2023-06-22 |
$LABS
MediPharm Labs Corp. |
Hunter, Gregory Edison
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$23,914
+398,582 vol $0.06 each |
748,674 | |
| Filed 2023-06-27 12:39 Tx date 2023-06-22 |
$LABS
MediPharm Labs Corp. |
Pidduck, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Units
57 - Exercise of rights
|
$-96,878.76
-1,614,646 vol $0.06 each |
8,166,369 | |
| Filed 2023-06-27 12:37 Tx date 2023-06-22 |
$LABS
MediPharm Labs Corp. |
Pidduck, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$96,878
+1,614,646 vol $0.06 each |
7,790,381 | |
| Filed 2023-05-29 16:30 Tx date 2023-05-19 |
$LABS
MediPharm Labs Corp. |
Strachan, Keith
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$8,306
+110,748 vol $0.075 each |
1,251,948 | |
| Filed 2023-05-24 16:34 Tx date 2023-05-19 |
$LABS
MediPharm Labs Corp. |
Pidduck, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-142,181.34
-2,031,162 vol $0.07 each |
6,175,735 | |
| Filed 2023-05-24 16:33 Tx date 2023-05-19 |
$LABS
MediPharm Labs Corp. |
Pidduck, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Units
57 - Exercise of rights
|
$-232,586.273
-3,275,863 vol $0.071 each |
9,781,015 | |
| Filed 2023-05-24 16:33 Tx date 2023-05-19 |
$LABS
MediPharm Labs Corp. |
Pidduck, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$232,586
+3,275,863 vol $0.071 each |
8,206,897 | |
| Filed 2023-05-24 16:30 Tx date 2023-05-19 |
$LABS
MediPharm Labs Corp. |
Hunter, Gregory Edison
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Units
57 - Exercise of rights
|
$-10,088.325
-134,511 vol $0.075 each |
972,163 | |
| Filed 2023-05-24 16:28 Tx date 2023-05-19 |
$LABS
MediPharm Labs Corp. |
Hunter, Gregory Edison
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$10,088
+134,511 vol $0.075 each |
350,092 | |
| Filed 2023-04-06 13:27 Tx date 2023-04-01 |
$LABS
MediPharm Labs Corp. |
Bumby, Michael Scott
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
116,400 | ||
| Filed 2023-03-12 11:59 Tx date 2023-03-05 |
$LABS
MediPharm Labs Corp. |
Halyk, Christopher John
4 - Director of Issuer
Direct Ownership
|
Warrants
55 - Expiration of warrants
|
-86,000 vol |
0 | |
| Filed 2023-03-10 18:41 Tx date 2021-03-15 |
$LABS
MediPharm Labs Corp. |
Hunter, Gregory Edison
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Units
56 - Grant of rights
|
+235,051 vol |
235,051 | |
| Filed 2023-03-10 18:28 Tx date 2022-05-24 |
$LABS
MediPharm Labs Corp. |
Pidduck, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Units
57 - Exercise of rights
|
-1,655,172 vol |
6,620,690 | |
| Filed 2023-03-10 18:27 Tx date 2022-05-24 |
$LABS
MediPharm Labs Corp. |
Pidduck, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+1,655,172 vol |
1,655,172 | |
| Filed 2023-03-10 18:09 Tx date 2022-12-22 |
$LABS
MediPharm Labs Corp. |
Hunter, Gregory Edison
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Units
56 - Grant of rights
|
+797,163 vol |
1,106,674 | |
| Filed 2023-03-10 18:07 Tx date 2022-09-15 |
$LABS
MediPharm Labs Corp. |
Hunter, Gregory Edison
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Units
56 - Grant of rights
|
+47,010 vol |
||
| Filed 2023-03-10 18:07 Tx date 2022-07-01 |
$LABS
MediPharm Labs Corp. |
Hunter, Gregory Edison
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Units
56 - Grant of rights
|
+87,500 vol |
||
| Filed 2023-03-10 18:06 Tx date 2022-03-15 |
$LABS
MediPharm Labs Corp. |
Hunter, Gregory Edison
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Units
56 - Grant of rights
|
+47,010 vol |
||
| Filed 2023-03-10 18:06 Tx date 2022-01-27 |
$LABS
MediPharm Labs Corp. |
Hunter, Gregory Edison
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Units
56 - Grant of rights
|
+350,000 vol |
491,031 | |
| Filed 2023-03-10 18:04 Tx date 2021-03-15 |
$LABS
MediPharm Labs Corp. |
Hunter, Gregory Edison
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Units
56 - Grant of rights
|
+231,051 vol |
||
| Filed 2023-03-10 18:00 Tx date 2022-12-22 |
$LABS
MediPharm Labs Corp. |
Hunter, Gregory Edison
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+199,291 vol |
3,849,291 | |
| Filed 2023-03-10 17:59 Tx date 2022-09-15 |
$LABS
MediPharm Labs Corp. |
Hunter, Gregory Edison
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$4,850
+10,000 vol $0.485 each |
||
| Filed 2023-03-10 17:59 Tx date 2022-07-28 |
$LABS
MediPharm Labs Corp. |
Hunter, Gregory Edison
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$75,600
+120,000 vol $0.63 each |
||
| Filed 2023-03-10 17:59 Tx date 2022-07-01 |
$LABS
MediPharm Labs Corp. |
Hunter, Gregory Edison
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$97,500
+500,000 vol $0.195 each |
||
| Filed 2023-03-10 17:58 Tx date 2022-06-17 |
$LABS
MediPharm Labs Corp. |
Hunter, Gregory Edison
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$35,000
+200,000 vol $0.175 each |
||
| Filed 2023-03-10 17:57 Tx date 2022-03-15 |
$LABS
MediPharm Labs Corp. |
Hunter, Gregory Edison
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$4,850
+10,000 vol $0.485 each |
||
| Filed 2023-03-10 17:57 Tx date 2022-01-27 |
$LABS
MediPharm Labs Corp. |
Hunter, Gregory Edison
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+2,000,000 vol |
3,650,000 | |
| Filed 2023-03-10 17:48 Tx date 2021-12-17 |
$LABS
MediPharm Labs Corp. |
Hunter, Gregory Edison
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$175,000
+1,000,000 vol $0.175 each |
1,650,000 | |
| Filed 2023-03-10 17:44 Tx date 2021-09-15 |
$LABS
MediPharm Labs Corp. |
Hunter, Gregory Edison
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$4,850
+10,000 vol $0.485 each |
||
| Filed 2023-03-10 17:44 Tx date 2021-07-28 |
$LABS
MediPharm Labs Corp. |
Hunter, Gregory Edison
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$75,600
+120,000 vol $0.63 each |
||
| Filed 2023-03-10 17:43 Tx date 2021-03-15 |
$LABS
MediPharm Labs Corp. |
Hunter, Gregory Edison
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$24,250
+50,000 vol $0.485 each |
650,000 | |
| Filed 2023-03-10 17:41 Tx date 2021-02-08 |
$LABS
MediPharm Labs Corp. |
Hunter, Gregory Edison
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
600,000 | ||
| Filed 2023-03-10 17:29 Tx date 2022-12-22 |
$LABS
MediPharm Labs Corp. |
Pidduck, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Units
56 - Grant of rights
|
+3,229,291 vol |
13,056,877 | |
| Filed 2023-03-10 17:24 Tx date 2022-12-22 |
$LABS
MediPharm Labs Corp. |
Pidduck, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Units
56 - Grant of rights
|
-3,229,291 vol |
||
| Filed 2023-03-10 17:22 Tx date 2022-10-31 |
$LABS
MediPharm Labs Corp. |
Pidduck, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Units
56 - Grant of rights
|
+1,655,172 vol |
||
| Filed 2023-03-10 17:20 Tx date 2022-07-27 |
$LABS
MediPharm Labs Corp. |
Pidduck, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Units
56 - Grant of rights
|
+6,482,759 vol |
13,103,448 | |
| Filed 2023-03-10 17:17 Tx date 2022-05-05 |
$LABS
MediPharm Labs Corp. |
Pidduck, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Units
56 - Grant of rights
|
+1,655,173 vol |
||
| Filed 2023-03-10 17:15 Tx date 2022-04-20 |
$LABS
MediPharm Labs Corp. |
Pidduck, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Units
00 - Opening Balance-Initial SEDI Report
|
8,275,862 | ||
| Filed 2023-03-10 17:04 Tx date 2022-12-22 |
$LABS
MediPharm Labs Corp. |
Pidduck, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+824,823 vol |
6,008,473 | |
| Filed 2023-03-10 16:54 Tx date 2022-10-31 |
$LABS
MediPharm Labs Corp. |
Pidduck, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$84,305
+581,415 vol $0.145 each |
||
| Filed 2023-03-10 16:52 Tx date 2022-07-27 |
$LABS
MediPharm Labs Corp. |
Pidduck, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$330,103
+2,276,577 vol $0.145 each |
5,183,650 | |
| Filed 2023-03-10 16:50 Tx date 2022-05-05 |
$LABS
MediPharm Labs Corp. |
Pidduck, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$84,305
+581,415 vol $0.145 each |
||
| Filed 2023-03-10 16:48 Tx date 2022-04-20 |
$LABS
MediPharm Labs Corp. |
Pidduck, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
2,907,073 | ||
| Filed 2023-03-10 16:20 Tx date 2023-03-05 |
$LABS
MediPharm Labs Corp. |
McDonald, Miriam
4 - Director of Issuer
Direct Ownership
|
Warrants
55 - Expiration of warrants
|
-17,000 vol |
0 | |
| Filed 2023-03-10 15:37 Tx date 2023-03-05 |
$LABS
MediPharm Labs Corp. |
Taves, Christopher David
4 - Director of Issuer
Direct Ownership
|
Warrants
55 - Expiration of warrants
|
$-490,000
-700,000 vol $0.70 each |
0 | |
| Filed 2022-10-31 13:15 Tx date 2022-10-31 |
$LABS
MediPharm Labs Corp. |
Pidduck, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Units
56 - Grant of rights
|
+1,655,172 vol |
||
| Filed 2022-10-31 13:13 Tx date 2022-10-31 |
$LABS
MediPharm Labs Corp. |
Pidduck, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$84,305
+581,415 vol $0.145 each |
||
| Filed 2022-09-16 13:42 Tx date 2022-09-15 |
$LABS
MediPharm Labs Corp. |
Hunter, Gregory Edison
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$4,850
+10,000 vol $0.485 each |
||
| Filed 2022-09-16 13:39 Tx date 2022-09-15 |
$LABS
MediPharm Labs Corp. |
Hunter, Gregory Edison
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Units
56 - Grant of rights
|
+47,010 vol |
||
| Filed 2022-08-08 16:15 Tx date 2022-08-05 |
$LABS
MediPharm Labs Corp. |
Pidduck, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Units
56 - Grant of rights
|
+1,620,690 vol |
||
| Filed 2022-08-08 16:14 Tx date 2022-08-05 |
$LABS
MediPharm Labs Corp. |
Pidduck, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$82,526
+569,145 vol $0.145 each |
||
| Filed 2022-08-08 16:11 Tx date 2022-08-05 |
$LABS
MediPharm Labs Corp. |
Pidduck, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$330,103
+2,276,577 vol $0.145 each |
||
| Filed 2022-07-28 12:52 Tx date 2022-07-28 |
$LABS
MediPharm Labs Corp. |
Hunter, Gregory Edison
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$75,600
+120,000 vol $0.63 each |
||
| Filed 2022-07-11 13:21 Tx date 2022-05-05 |
$LABS
MediPharm Labs Corp. |
Pidduck, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Units
56 - Grant of rights
|
+1,655,173 vol |
||
| Filed 2022-07-11 13:20 Tx date 2022-05-05 |
$LABS
MediPharm Labs Corp. |
Pidduck, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$84,305
+581,415 vol $0.145 each |
||
| Filed 2022-07-04 12:35 Tx date 2022-07-01 |
$LABS
MediPharm Labs Corp. |
Hunter, Gregory Edison
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Units
56 - Grant of rights
|
+87,500 vol |
||
| Filed 2022-07-04 12:31 Tx date 2022-07-01 |
$LABS
MediPharm Labs Corp. |
Hunter, Gregory Edison
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$97,500
+500,000 vol $0.195 each |
||
| Filed 2022-06-22 17:50 Tx date 2022-06-17 |
$LABS
MediPharm Labs Corp. |
Hunter, Gregory Edison
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$35,000
+200,000 vol $0.175 each |
||
| Filed 2022-05-31 17:30 Tx date 2022-05-24 |
$LABS
MediPharm Labs Corp. |
Pidduck, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+1,655,173 vol |
||
| Filed 2022-05-31 17:29 Tx date 2022-05-24 |
$LABS
MediPharm Labs Corp. |
Pidduck, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Units
57 - Exercise of rights
|
-1,655,173 vol |
||
| Filed 2022-05-05 16:00 Tx date 2022-04-20 |
$LABS
MediPharm Labs Corp. |
Pidduck, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Units
56 - Grant of rights
|
+1,655,173 vol |
||
| Filed 2022-05-05 15:59 Tx date 2022-04-20 |
$LABS
MediPharm Labs Corp. |
Pidduck, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-05-05 15:58 Tx date 2022-04-19 |
$LABS
MediPharm Labs Corp. |
Pidduck, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$84,305
+581,415 vol $0.145 each |
||
| Filed 2022-05-05 15:56 Tx date 2022-04-20 |
$LABS
MediPharm Labs Corp. |
Pidduck, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-03-17 12:10 Tx date 2022-03-15 |
$LABS
MediPharm Labs Corp. |
Hunter, Gregory Edison
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Units
56 - Grant of rights
|
+47,010 vol |
||
| Filed 2022-03-17 12:09 Tx date 2022-03-15 |
$LABS
MediPharm Labs Corp. |
Hunter, Gregory Edison
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$4,850
+10,000 vol $0.485 each |
||
| Filed 2022-03-17 12:06 Tx date 2022-03-15 |
$LABS
MediPharm Labs Corp. |
Hunter, Gregory Edison
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Units
56 - Grant of rights
|
+47,010 vol |
||
| Filed 2022-02-03 17:23 Tx date 2022-01-28 |
$LABS
MediPharm Labs Corp. |
Hunter, Gregory Edison
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$75,600
+120,000 vol $0.63 each |
||
| Filed 2021-12-29 12:17 Tx date 2021-12-17 |
$LABS
MediPharm Labs Corp. |
Hunter, Gregory Edison
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$35,000
+200,000 vol $0.175 each |
||
| Filed 2021-11-22 14:02 Tx date 2021-09-15 |
$LABS
MediPharm Labs Corp. |
Hunter, Gregory Edison
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Units
56 - Grant of rights
|
+47,010 vol |
||
| Filed 2021-11-22 14:01 Tx date 2021-03-15 |
$LABS
MediPharm Labs Corp. |
Hunter, Gregory Edison
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Units
56 - Grant of rights
|
+47,010 vol |
||
| Filed 2021-11-22 12:25 Tx date 2021-09-15 |
$LABS
MediPharm Labs Corp. |
Hunter, Gregory Edison
5 - Senior Officer of Issuer
Direct Ownership
|
Options Restricted Stock Units
50 - Grant of options
|
+47,010 vol |
||
| Filed 2021-11-22 12:23 Tx date 2021-03-15 |
$LABS
MediPharm Labs Corp. |
Hunter, Gregory Edison
5 - Senior Officer of Issuer
Direct Ownership
|
Options Restricted Stock Units
50 - Grant of options
|
+47,010 vol |
||
| Filed 2021-11-22 12:06 Tx date 2021-09-15 |
$LABS
MediPharm Labs Corp. |
Hunter, Gregory Edison
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$4,850
+10,000 vol $0.485 each |
||
| Filed 2021-11-22 12:05 Tx date 2021-03-15 |
$LABS
MediPharm Labs Corp. |
Hunter, Gregory Edison
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$4,850
+10,000 vol $0.485 each |
||
| Filed 2021-11-22 12:03 Tx date 2021-07-28 |
$LABS
MediPharm Labs Corp. |
Hunter, Gregory Edison
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$75,600
+120,000 vol $0.63 each |
||
| Filed 2021-02-12 15:51 Tx date 2021-02-08 |
$LABS
MediPharm Labs Corp. |
Hunter, Gregory Edison
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-11-17 14:15 Tx date 2022-11-15 |
$LABS
MediPharm Labs Corp. |
Pidduck, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+1,655,172 vol |
4,931,035 | |
| Filed 2022-11-17 14:14 Tx date 2022-11-15 |
$LABS
MediPharm Labs Corp. |
Pidduck, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Units
57 - Exercise of rights
|
-1,655,172 vol |
0 | |
| Filed 2022-10-31 13:15 Tx date 2022-10-31 |
$LABS
MediPharm Labs Corp. |
Pidduck, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Units
56 - Grant of rights
|
+1,655,172 vol |
1,655,172 | |
| Filed 2022-10-31 13:13 Tx date 2022-10-31 |
$LABS
MediPharm Labs Corp. |
Pidduck, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$84,305
+581,415 vol $0.145 each |
1,731,975 | |
| Filed 2022-09-16 13:42 Tx date 2022-09-15 |
$LABS
MediPharm Labs Corp. |
Hunter, Gregory Edison
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$4,850
+10,000 vol $0.485 each |
1,420,000 | |
| Filed 2022-09-16 13:41 Tx date 2022-09-15 |
$LABS
MediPharm Labs Corp. |
Hunter, Gregory Edison
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+47,010 vol |
215,581 | |
| Filed 2022-09-16 13:40 Tx date 2022-09-15 |
$LABS
MediPharm Labs Corp. |
Hunter, Gregory Edison
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Units
57 - Exercise of rights
|
-47,010 vol |
0 | |
| Filed 2022-09-16 13:39 Tx date 2022-09-15 |
$LABS
MediPharm Labs Corp. |
Hunter, Gregory Edison
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Units
56 - Grant of rights
|
+47,010 vol |
47,010 | |
| Filed 2022-08-19 10:57 Tx date 2022-08-15 |
$LABS
MediPharm Labs Corp. |
Hunter, Gregory Edison
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+87,500 vol |
168,571 | |
| Filed 2022-08-19 10:56 Tx date 2022-08-15 |
$LABS
MediPharm Labs Corp. |
Hunter, Gregory Edison
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Units
57 - Exercise of rights
|
-87,500 vol |
0 | |
| Filed 2022-08-19 10:37 Tx date 2022-08-15 |
$LABS
MediPharm Labs Corp. |
Pidduck, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+1,620,690 vol |
3,275,863 | |
| Filed 2022-08-19 10:35 Tx date 2022-08-15 |
$LABS
MediPharm Labs Corp. |
Pidduck, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Units
57 - Exercise of rights
|
-1,620,690 vol |
0 | |
| Filed 2022-08-19 10:34 Tx date 2022-08-15 |
$LABS
MediPharm Labs Corp. |
Pidduck, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+1,620,690 vol |
||
| Filed 2022-08-19 10:33 Tx date 2022-08-15 |
$LABS
MediPharm Labs Corp. |
Pidduck, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Units
57 - Exercise of rights
|
+1,620,690 vol |
||
| Filed 2022-08-08 16:15 Tx date 2022-08-05 |
$LABS
MediPharm Labs Corp. |
Pidduck, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Units
56 - Grant of rights
|
+1,620,690 vol |
1,620,690 | |
| Filed 2022-08-08 16:14 Tx date 2022-08-05 |
$LABS
MediPharm Labs Corp. |
Pidduck, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$82,526
+569,145 vol $0.145 each |
1,150,560 | |
| Filed 2022-08-08 16:11 Tx date 2022-08-05 |
$LABS
MediPharm Labs Corp. |
Pidduck, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$330,103
+2,276,577 vol $0.145 each |
||
| Filed 2022-07-28 12:52 Tx date 2022-07-28 |
$LABS
MediPharm Labs Corp. |
Hunter, Gregory Edison
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$75,600
+120,000 vol $0.63 each |
1,410,000 | |
| Filed 2022-07-11 13:21 Tx date 2022-05-05 |
$LABS
MediPharm Labs Corp. |
Pidduck, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Units
56 - Grant of rights
|
+1,655,173 vol |
1,655,173 | |
| Filed 2022-07-11 13:20 Tx date 2022-05-05 |
$LABS
MediPharm Labs Corp. |
Pidduck, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$84,305
+581,415 vol $0.145 each |
581,415 | |
| Filed 2022-05-05 16:00 Tx date 2022-04-20 |
$LABS
MediPharm Labs Corp. |
Pidduck, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Units
56 - Grant of rights
|
+1,655,173 vol |
||
| Filed 2022-05-05 15:58 Tx date 2022-04-19 |
$LABS
MediPharm Labs Corp. |
Pidduck, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$84,305
+581,415 vol $0.145 each |
||
| Filed 2022-07-04 12:35 Tx date 2022-07-01 |
$LABS
MediPharm Labs Corp. |
Hunter, Gregory Edison
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Units
56 - Grant of rights
|
+87,500 vol |
87,500 | |
| Filed 2022-07-04 12:31 Tx date 2022-07-01 |
$LABS
MediPharm Labs Corp. |
Hunter, Gregory Edison
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$97,500
+500,000 vol $0.195 each |
1,290,000 | |
| Filed 2022-06-22 17:50 Tx date 2022-06-17 |
$LABS
MediPharm Labs Corp. |
Hunter, Gregory Edison
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$35,000
+200,000 vol $0.175 each |
790,000 | |
| Filed 2022-05-31 17:43 Tx date 2022-05-17 |
$LABS
MediPharm Labs Corp. |
Hunter, Gregory Edison
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+47,010 vol |
81,071 | |
| Filed 2022-05-31 17:42 Tx date 2022-05-17 |
$LABS
MediPharm Labs Corp. |
Hunter, Gregory Edison
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Units
57 - Exercise of rights
|
-47,010 vol |
0 | |
| Filed 2022-05-31 17:30 Tx date 2022-05-24 |
$LABS
MediPharm Labs Corp. |
Pidduck, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+1,655,173 vol |
1,655,173 | |
| Filed 2022-05-31 17:29 Tx date 2022-04-20 |
$LABS
MediPharm Labs Corp. |
Pidduck, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-05-31 17:29 Tx date 2022-05-24 |
$LABS
MediPharm Labs Corp. |
Pidduck, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Units
57 - Exercise of rights
|
-1,655,173 vol |
0 | |
| Filed 2022-05-05 16:00 Tx date 2022-04-20 |
$LABS
MediPharm Labs Corp. |
Pidduck, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Units
56 - Grant of rights
|
+1,655,173 vol |
1,655,173 | |
| Filed 2022-05-05 15:59 Tx date 2022-04-20 |
$LABS
MediPharm Labs Corp. |
Pidduck, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-05-05 15:58 Tx date 2022-04-19 |
$LABS
MediPharm Labs Corp. |
Pidduck, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$84,305
+581,415 vol $0.145 each |
581,415 | |
| Filed 2022-05-05 15:56 Tx date 2022-04-20 |
$LABS
MediPharm Labs Corp. |
Pidduck, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-03-18 12:28 Tx date 2022-03-15 |
$LABS
MediPharm Labs Corp. |
Everitt, Warren
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Restricted Stock Units
56 - Grant of rights
|
+44,536 vol |
44,536 | |
| Filed 2022-03-18 12:27 Tx date 2022-03-15 |
$LABS
MediPharm Labs Corp. |
Everitt, Warren
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
50 - Grant of options
|
$4,850
+10,000 vol $0.485 each |
180,000 | |
| Filed 2022-03-17 12:10 Tx date 2022-03-15 |
$LABS
MediPharm Labs Corp. |
Hunter, Gregory Edison
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Units
56 - Grant of rights
|
+47,010 vol |
47,010 | |
| Filed 2022-03-17 12:09 Tx date 2022-03-15 |
$LABS
MediPharm Labs Corp. |
Hunter, Gregory Edison
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$4,850
+10,000 vol $0.485 each |
590,000 | |
| Filed 2022-03-17 12:06 Tx date 2022-03-15 |
$LABS
MediPharm Labs Corp. |
Hunter, Gregory Edison
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Units
56 - Grant of rights
|
+47,010 vol |
||
| Filed 2022-02-03 17:23 Tx date 2022-01-28 |
$LABS
MediPharm Labs Corp. |
Hunter, Gregory Edison
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$75,600
+120,000 vol $0.63 each |
580,000 | |
| Filed 2022-01-11 18:51 Tx date 2021-09-15 |
$LABS
MediPharm Labs Corp. |
Hunter, Gregory Edison
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-9,331.7361
-29,919 vol $0.3119 each |
34,061 | |
| Filed 2022-01-11 18:51 Tx date 2021-05-19 |
$LABS
MediPharm Labs Corp. |
Hunter, Gregory Edison
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-12,124.144
-30,040 vol $0.4036 each |
16,970 | |
| Filed 2022-01-11 18:45 Tx date 2021-09-15 |
$LABS
MediPharm Labs Corp. |
Hunter, Gregory Edison
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$14,662
+47,010 vol $0.3119 each |
63,980 | |
| Filed 2022-01-11 18:43 Tx date 2021-05-19 |
$LABS
MediPharm Labs Corp. |
Hunter, Gregory Edison
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$-12,124.144
-30,040 vol $0.4036 each |
||
| Filed 2022-01-11 18:40 Tx date 2021-05-19 |
$LABS
MediPharm Labs Corp. |
Hunter, Gregory Edison
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$18,973
+47,010 vol $0.4036 each |
47,010 | |
| Filed 2022-01-11 18:38 Tx date 2022-01-07 |
$LABS
MediPharm Labs Corp. |
Howcroft, Bryan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+401,785 vol |
501,785 | |
| Filed 2022-01-11 18:36 Tx date 2021-10-20 |
$LABS
MediPharm Labs Corp. |
Howcroft, Bryan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Units
56 - Grant of rights
|
+401,785 vol |
401,785 | |
| Filed 2022-01-11 18:36 Tx date 2022-01-07 |
$LABS
MediPharm Labs Corp. |
Howcroft, Bryan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Units
57 - Exercise of rights
|
-401,785 vol |
0 | |
| Filed 2022-01-04 12:44 Tx date 2021-10-20 |
$LABS
MediPharm Labs Corp. |
Howcroft, Bryan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Units
56 - Grant of rights
|
+401,786 vol |
||
| Filed 2021-11-22 14:30 Tx date 2021-09-15 |
$LABS
MediPharm Labs Corp. |
Hunter, Gregory Edison
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$-9,331.7361
-29,919 vol $0.3119 each |
||
| Filed 2021-11-22 14:28 Tx date 2021-09-15 |
$LABS
MediPharm Labs Corp. |
Hunter, Gregory Edison
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$14,662
+47,010 vol $0.3119 each |
||
| Filed 2021-11-22 14:28 Tx date 2021-05-19 |
$LABS
MediPharm Labs Corp. |
Hunter, Gregory Edison
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$-12,124.144
-30,040 vol $0.4036 each |
||
| Filed 2021-11-22 14:27 Tx date 2021-05-19 |
$LABS
MediPharm Labs Corp. |
Hunter, Gregory Edison
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$18,973
+47,010 vol $0.4036 each |
||
| Filed 2022-01-04 12:44 Tx date 2021-10-20 |
$LABS
MediPharm Labs Corp. |
Howcroft, Bryan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Units
56 - Grant of rights
|
+401,786 vol |
401,786 | |
| Filed 2022-01-04 12:39 Tx date 2021-11-15 |
$LABS
MediPharm Labs Corp. |
Howcroft, Bryan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-01-04 12:35 Tx date 2021-10-20 |
$LABS
MediPharm Labs Corp. |
Howcroft, Bryan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$53,307
+190,384 vol $0.28 each |
190,384 | |
| Filed 2022-01-04 12:33 Tx date 2021-11-15 |
$LABS
MediPharm Labs Corp. |
Howcroft, Bryan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-12-29 12:17 Tx date 2021-12-17 |
$LABS
MediPharm Labs Corp. |
Hunter, Gregory Edison
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$35,000
+200,000 vol $0.175 each |
460,000 | |
| Filed 2021-11-26 12:04 Tx date 2021-11-26 |
$LABS
MediPharm Labs Corp. |
Howcroft, Bryan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$22,500
+100,000 vol $0.225 each |
100,000 | |
| Filed 2021-11-26 12:04 Tx date 2021-11-15 |
$LABS
MediPharm Labs Corp. |
Howcroft, Bryan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-11-23 10:00 Tx date 2021-11-19 |
$LABS
MediPharm Labs Corp. |
McCutcheon, Patrick
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-345.00
-1,500 vol $0.23 each |
7,565,240 | |
| Filed 2021-11-23 09:59 Tx date 2021-11-18 |
$LABS
MediPharm Labs Corp. |
McCutcheon, Patrick
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-76,727.50
-326,500 vol $0.235 each |
7,566,740 | |
| Filed 2021-11-23 09:58 Tx date 2021-11-17 |
$LABS
MediPharm Labs Corp. |
McCutcheon, Patrick
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-42,140
-172,000 vol $0.245 each |
7,893,240 | |
| Filed 2021-11-23 09:43 Tx date 2018-10-01 |
$LABS
MediPharm Labs Corp. |
McCutcheon, Patrick
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
8,065,240 | ||
| Filed 2021-11-22 14:30 Tx date 2021-09-15 |
$LABS
MediPharm Labs Corp. |
Hunter, Gregory Edison
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$-9,331.7361
-29,919 vol $0.3119 each |
34,061 | |
| Filed 2021-11-22 14:28 Tx date 2021-09-15 |
$LABS
MediPharm Labs Corp. |
Hunter, Gregory Edison
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$14,662
+47,010 vol $0.3119 each |
63,980 | |
| Filed 2021-11-22 14:28 Tx date 2021-05-19 |
$LABS
MediPharm Labs Corp. |
Hunter, Gregory Edison
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$-12,124.144
-30,040 vol $0.4036 each |
16,970 | |
| Filed 2021-11-22 14:27 Tx date 2021-05-19 |
$LABS
MediPharm Labs Corp. |
Hunter, Gregory Edison
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$18,973
+47,010 vol $0.4036 each |
47,010 | |
| Filed 2021-11-22 14:26 Tx date 2021-02-08 |
$LABS
MediPharm Labs Corp. |
Hunter, Gregory Edison
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-11-22 14:22 Tx date 2021-09-15 |
$LABS
MediPharm Labs Corp. |
Everitt, Warren
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$13,890
+44,536 vol $0.3119 each |
2,431,089 | |
| Filed 2021-11-22 14:21 Tx date 2021-09-15 |
$LABS
MediPharm Labs Corp. |
Everitt, Warren
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$-13,890.7784
-44,536 vol $0.3119 each |
2,386,553 | |
| Filed 2021-11-22 14:20 Tx date 2021-09-15 |
$LABS
MediPharm Labs Corp. |
Everitt, Warren
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$13,890
+44,536 vol $0.3119 each |
||
| Filed 2021-11-22 14:20 Tx date 2021-05-19 |
$LABS
MediPharm Labs Corp. |
Everitt, Warren
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$-17,974.7296
-44,536 vol $0.4036 each |
2,386,553 | |
| Filed 2021-11-22 14:19 Tx date 2021-05-19 |
$LABS
MediPharm Labs Corp. |
Everitt, Warren
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$17,974
+44,536 vol $0.4036 each |
2,431,089 | |
| Filed 2021-11-22 14:15 Tx date 2021-09-15 |
$LABS
MediPharm Labs Corp. |
Everitt, Warren
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Restricted Stock Units
57 - Exercise of rights
|
-44,536 vol |
0 | |
| Filed 2021-11-22 14:14 Tx date 2021-09-15 |
$LABS
MediPharm Labs Corp. |
Everitt, Warren
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Restricted Stock Units
56 - Grant of rights
|
+44,536 vol |
44,536 | |
| Filed 2021-11-22 14:09 Tx date 2021-03-15 |
$LABS
MediPharm Labs Corp. |
Everitt, Warren
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Restricted Stock Units
56 - Grant of rights
|
+44,536 vol |
44,536 | |
| Filed 2021-11-22 14:08 Tx date 2021-05-19 |
$LABS
MediPharm Labs Corp. |
Everitt, Warren
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Restricted Stock Units
57 - Exercise of rights
|
-44,536 vol |
0 | |
| Filed 2021-11-22 14:06 Tx date 2021-03-15 |
$LABS
MediPharm Labs Corp. |
Everitt, Warren
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Restricted Stock Units
56 - Grant of rights
|
+44,536 vol |
||
| Filed 2021-11-22 14:05 Tx date 2018-10-01 |
$LABS
MediPharm Labs Corp. |
Everitt, Warren
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Restricted Stock Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-11-22 14:03 Tx date 2021-02-08 |
$LABS
MediPharm Labs Corp. |
Hunter, Gregory Edison
5 - Senior Officer of Issuer
Direct Ownership
|
Options Restricted Stock Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-11-22 14:03 Tx date 2021-09-15 |
$LABS
MediPharm Labs Corp. |
Hunter, Gregory Edison
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Units
57 - Exercise of rights
|
-47,010 vol |
0 | |
| Filed 2021-11-22 14:02 Tx date 2021-09-15 |
$LABS
MediPharm Labs Corp. |
Hunter, Gregory Edison
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Units
56 - Grant of rights
|
+47,010 vol |
47,010 | |
| Filed 2021-11-22 14:01 Tx date 2021-05-19 |
$LABS
MediPharm Labs Corp. |
Hunter, Gregory Edison
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Units
57 - Exercise of rights
|
-47,010 vol |
0 | |
| Filed 2021-11-22 14:01 Tx date 2021-03-15 |
$LABS
MediPharm Labs Corp. |
Hunter, Gregory Edison
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Units
56 - Grant of rights
|
+47,010 vol |
47,010 | |
| Filed 2021-11-22 13:57 Tx date 2021-02-08 |
$LABS
MediPharm Labs Corp. |
Hunter, Gregory Edison
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-11-22 13:47 Tx date 2021-11-19 |
$LABS
MediPharm Labs Corp. |
Everitt, Warren
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-86,520.4818
-359,603 vol $0.2406 each |
2,026,950 | |
| Filed 2021-11-22 13:45 Tx date 2021-09-15 |
$LABS
MediPharm Labs Corp. |
Everitt, Warren
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
50 - Grant of options
|
$4,850
+10,000 vol $0.485 each |
170,000 | |
| Filed 2021-11-22 13:44 Tx date 2021-03-15 |
$LABS
MediPharm Labs Corp. |
Everitt, Warren
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
50 - Grant of options
|
$4,850
+10,000 vol $0.485 each |
160,000 | |
| Filed 2021-11-22 12:34 Tx date 2021-09-15 |
$LABS
MediPharm Labs Corp. |
Hunter, Gregory Edison
5 - Senior Officer of Issuer
Direct Ownership
|
Options Restricted Stock Units
36 - Conversion or exchange
|
-47,010 vol |
0 | |
| Filed 2021-11-22 12:34 Tx date 2021-09-15 |
$LABS
MediPharm Labs Corp. |
Hunter, Gregory Edison
5 - Senior Officer of Issuer
Direct Ownership
|
Options Restricted Stock Units
36 - Conversion or exchange
|
-47,010 vol |
||
| Filed 2021-11-22 12:34 Tx date 2021-09-15 |
$LABS
MediPharm Labs Corp. |
Hunter, Gregory Edison
5 - Senior Officer of Issuer
Direct Ownership
|
Options Restricted Stock Units
50 - Grant of options
|
+47,010 vol |
||
| Filed 2021-11-22 12:31 Tx date 2021-09-15 |
$LABS
MediPharm Labs Corp. |
Hunter, Gregory Edison
5 - Senior Officer of Issuer
Direct Ownership
|
Options Restricted Stock Units
50 - Grant of options
|
+47,010 vol |
||
| Filed 2021-11-22 12:26 Tx date 2021-09-15 |
$LABS
MediPharm Labs Corp. |
Hunter, Gregory Edison
5 - Senior Officer of Issuer
Direct Ownership
|
Options Restricted Stock Units
36 - Conversion or exchange
|
-47,010 vol |
||
| Filed 2021-11-22 12:26 Tx date 2021-09-15 |
$LABS
MediPharm Labs Corp. |
Hunter, Gregory Edison
5 - Senior Officer of Issuer
Direct Ownership
|
Options Restricted Stock Units
36 - Conversion or exchange
|
-47,010 vol |
||
| Filed 2021-11-22 12:25 Tx date 2021-09-15 |
$LABS
MediPharm Labs Corp. |
Hunter, Gregory Edison
5 - Senior Officer of Issuer
Direct Ownership
|
Options Restricted Stock Units
50 - Grant of options
|
+47,010 vol |
47,010 | |
| Filed 2021-11-22 12:25 Tx date 2021-09-15 |
$LABS
MediPharm Labs Corp. |
Hunter, Gregory Edison
5 - Senior Officer of Issuer
Direct Ownership
|
Options Restricted Stock Units
50 - Grant of options
|
+47,010 vol |
||
| Filed 2021-11-22 12:24 Tx date 2021-05-19 |
$LABS
MediPharm Labs Corp. |
Hunter, Gregory Edison
5 - Senior Officer of Issuer
Direct Ownership
|
Options Restricted Stock Units
36 - Conversion or exchange
|
-47,010 vol |
0 | |
| Filed 2021-11-22 12:24 Tx date 2021-05-19 |
$LABS
MediPharm Labs Corp. |
Hunter, Gregory Edison
5 - Senior Officer of Issuer
Direct Ownership
|
Options Restricted Stock Units
36 - Conversion or exchange
|
-47,010 vol |
||
| Filed 2021-11-22 12:23 Tx date 2021-03-15 |
$LABS
MediPharm Labs Corp. |
Hunter, Gregory Edison
5 - Senior Officer of Issuer
Direct Ownership
|
Options Restricted Stock Units
50 - Grant of options
|
+47,010 vol |
47,010 | |
| Filed 2021-11-22 12:23 Tx date 2021-03-15 |
$LABS
MediPharm Labs Corp. |
Hunter, Gregory Edison
5 - Senior Officer of Issuer
Direct Ownership
|
Options Restricted Stock Units
50 - Grant of options
|
+47,010 vol |
||
| Filed 2021-11-22 12:20 Tx date 2021-02-08 |
$LABS
MediPharm Labs Corp. |
Hunter, Gregory Edison
5 - Senior Officer of Issuer
Direct Ownership
|
Options Restricted Stock Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-11-22 12:20 Tx date 2021-02-08 |
$LABS
MediPharm Labs Corp. |
Hunter, Gregory Edison
5 - Senior Officer of Issuer
Direct Ownership
|
Options Restricted Stock Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-11-22 12:06 Tx date 2021-09-15 |
$LABS
MediPharm Labs Corp. |
Hunter, Gregory Edison
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$4,850
+10,000 vol $0.485 each |
260,000 | |
| Filed 2021-11-22 12:05 Tx date 2021-03-15 |
$LABS
MediPharm Labs Corp. |
Hunter, Gregory Edison
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$4,850
+10,000 vol $0.485 each |
130,000 | |
| Filed 2021-11-22 12:03 Tx date 2021-07-28 |
$LABS
MediPharm Labs Corp. |
Hunter, Gregory Edison
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$75,600
+120,000 vol $0.63 each |
250,000 | |
| Filed 2021-08-17 17:41 Tx date 2021-08-01 |
$LABS
MediPharm Labs Corp. |
ETF Managers Trust
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-765,451.86
-2,014,347 vol $0.38 each |
||
| Filed 2021-08-17 17:40 Tx date 2021-08-13 |
$LABS
MediPharm Labs Corp. |
ETF Managers Trust
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-765,451.86
-2,014,347 vol $0.38 each |
25,464,225 | |
| Filed 2021-08-17 17:25 Tx date 2021-08-01 |
$LABS
MediPharm Labs Corp. |
ETF Managers Trust
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-765,451.86
-2,014,347 vol $0.38 each |
||
| Filed 2021-08-17 17:23 Tx date 2021-08-09 |
$LABS
MediPharm Labs Corp. |
ETF Managers Trust
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$70,299
+173,580 vol $0.405 each |
27,478,572 | |
| Filed 2021-08-17 17:20 Tx date 2021-08-04 |
$LABS
MediPharm Labs Corp. |
ETF Managers Trust
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-20,829.60
-52,074 vol $0.40 each |
27,304,992 | |
| Filed 2021-08-17 17:05 Tx date 2021-05-28 |
$LABS
MediPharm Labs Corp. |
ETF Managers Trust
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,438,451
+16,273,192 vol $0.58 each |
27,357,066 | |
| Filed 2021-08-17 17:04 Tx date 2021-05-28 |
$LABS
MediPharm Labs Corp. |
ETF Managers Trust
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
11,083,874 | ||
| Filed 2021-06-28 10:41 Tx date 2021-06-24 |
$LABS
MediPharm Labs Corp. |
McCutcheon, Patrick
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-138,000
-300,000 vol $0.46 each |
86,000 | |
| Filed 2021-06-24 11:53 Tx date 2021-06-23 |
$LABS
MediPharm Labs Corp. |
McCutcheon, Patrick
4 - Director of Issuer
Direct Ownership
|
Warrants
10 - Acquisition or disposition in the public market
|
$1,350
+15,000 vol $0.09 each |
286,000 | |
| Filed 2021-06-24 11:52 Tx date 2021-06-22 |
$LABS
MediPharm Labs Corp. |
McCutcheon, Patrick
4 - Director of Issuer
Direct Ownership
|
Warrants
10 - Acquisition or disposition in the public market
|
$2,880
+32,000 vol $0.09 each |
271,000 | |
| Filed 2021-06-24 10:59 Tx date 2021-06-18 |
$LABS
MediPharm Labs Corp. |
McCutcheon, Patrick
4 - Director of Issuer
Direct Ownership
|
Warrants
10 - Acquisition or disposition in the public market
|
$9,000
+100,000 vol $0.09 each |
186,000 | |
| Filed 2021-06-24 10:57 Tx date 2021-06-21 |
$LABS
MediPharm Labs Corp. |
McCutcheon, Patrick
4 - Director of Issuer
Direct Ownership
|
Warrants
10 - Acquisition or disposition in the public market
|
$4,770
+53,000 vol $0.09 each |
239,000 | |
| Filed 2021-06-24 10:55 Tx date 2021-06-18 |
$LABS
MediPharm Labs Corp. |
McCutcheon, Patrick
4 - Director of Issuer
Direct Ownership
|
Warrants
10 - Acquisition or disposition in the public market
|
$9,000
+100,000 vol $0.09 each |
||
| Filed 2021-06-15 10:19 Tx date 2021-06-11 |
$LABS
MediPharm Labs Corp. |
McCutcheon, Patrick
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-93,000
-186,000 vol $0.50 each |
386,000 | |
| Filed 2021-06-15 10:14 Tx date 2021-06-09 |
$LABS
MediPharm Labs Corp. |
McCutcheon, Patrick
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-151,410
-309,000 vol $0.49 each |
572,000 | |
| Filed 2021-06-15 10:12 Tx date 2021-06-08 |
$LABS
MediPharm Labs Corp. |
McCutcheon, Patrick
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-2,500
-5,000 vol $0.50 each |
881,000 | |
| Filed 2021-06-15 10:11 Tx date 2021-06-07 |
$LABS
MediPharm Labs Corp. |
McCutcheon, Patrick
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-234,000
-468,000 vol $0.50 each |
886,000 | |
| Filed 2021-05-27 17:51 Tx date 2021-05-20 |
$LABS
MediPharm Labs Corp. |
Taves, Christopher David
4 - Director of Issuer
Direct Ownership
|
Warrants
10 - Acquisition or disposition in the public market
|
$1,245
+18,000 vol $0.0692 each |
363,000 | |
| Filed 2021-05-27 17:30 Tx date 2021-05-27 |
$LABS
MediPharm Labs Corp. |
Taves, Christopher David
4 - Director of Issuer
Direct Ownership
|
Warrants
10 - Acquisition or disposition in the public market
|
$19,718
+237,000 vol $0.0832 each |
700,000 | |
| Filed 2021-05-27 17:29 Tx date 2021-05-26 |
$LABS
MediPharm Labs Corp. |
Taves, Christopher David
4 - Director of Issuer
Direct Ownership
|
Warrants
10 - Acquisition or disposition in the public market
|
$4,000
+50,000 vol $0.08 each |
463,000 | |
| Filed 2021-05-27 17:28 Tx date 2021-05-26 |
$LABS
MediPharm Labs Corp. |
Taves, Christopher David
4 - Director of Issuer
Direct Ownership
|
Warrants
10 - Acquisition or disposition in the public market
|
$4,000
+50,000 vol $0.08 each |
||
| Filed 2021-05-27 17:27 Tx date 2021-05-21 |
$LABS
MediPharm Labs Corp. |
Taves, Christopher David
4 - Director of Issuer
Direct Ownership
|
Warrants
10 - Acquisition or disposition in the public market
|
$3,700
+50,000 vol $0.074 each |
413,000 | |
| Filed 2021-05-27 17:24 Tx date 2021-05-20 |
$LABS
MediPharm Labs Corp. |
Taves, Christopher David
4 - Director of Issuer
Direct Ownership
|
Warrants
10 - Acquisition or disposition in the public market
|
$1,245
+18,000 vol $0.0692 each |
||
| Filed 2021-05-27 17:20 Tx date 2021-05-27 |
$LABS
MediPharm Labs Corp. |
Taves, Christopher David
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$105,919
+200,000 vol $0.53 each |
1,000,000 | |
| Filed 2021-05-27 17:18 Tx date 2021-05-26 |
$LABS
MediPharm Labs Corp. |
Taves, Christopher David
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$48,500
+100,000 vol $0.485 each |
800,000 | |
| Filed 2021-05-27 17:17 Tx date 2021-05-21 |
$LABS
MediPharm Labs Corp. |
Taves, Christopher David
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$40,500
+90,000 vol $0.45 each |
700,000 | |
| Filed 2021-05-27 17:16 Tx date 2021-05-20 |
$LABS
MediPharm Labs Corp. |
Taves, Christopher David
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$38,250
+90,000 vol $0.425 each |
610,000 | |
| Filed 2021-05-27 17:15 Tx date 2021-05-19 |
$LABS
MediPharm Labs Corp. |
Taves, Christopher David
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$70,875
+175,000 vol $0.405 each |
520,000 | |
| Filed 2021-05-27 17:14 Tx date 2021-05-20 |
$LABS
MediPharm Labs Corp. |
Taves, Christopher David
4 - Director of Issuer
Direct Ownership
|
Warrants
10 - Acquisition or disposition in the public market
|
$1,332
+18,000 vol $0.074 each |
||
| Filed 2021-05-27 17:12 Tx date 2021-05-20 |
$LABS
MediPharm Labs Corp. |
Taves, Christopher David
4 - Director of Issuer
Direct Ownership
|
Warrants
10 - Acquisition or disposition in the public market
|
$1,332
+18,000 vol $0.074 each |
||
| Filed 2021-05-27 17:09 Tx date 2021-05-27 |
$LABS
MediPharm Labs Corp. |
Taves, Christopher David
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$105,919
+200,000 vol $0.53 each |
||
| Filed 2021-05-27 17:08 Tx date 2021-05-26 |
$LABS
MediPharm Labs Corp. |
Taves, Christopher David
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$48,500
+100,000 vol $0.485 each |
||
| Filed 2021-05-27 17:07 Tx date 2021-05-21 |
$LABS
MediPharm Labs Corp. |
Taves, Christopher David
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$40,500
+90,000 vol $0.45 each |
||
| Filed 2021-05-27 17:07 Tx date 2021-05-20 |
$LABS
MediPharm Labs Corp. |
Taves, Christopher David
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$38,250
+90,000 vol $0.425 each |
||
| Filed 2021-05-27 17:05 Tx date 2021-05-19 |
$LABS
MediPharm Labs Corp. |
Taves, Christopher David
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$70,875
+175,000 vol $0.405 each |
||
| Filed 2021-03-12 10:47 Tx date 2021-03-05 |
$LABS
MediPharm Labs Corp. |
McCutcheon, Patrick
4 - Director of Issuer
Direct Ownership
|
Warrants
15 - Acquisition or disposition under a prospectus
|
$60,199
+86,000 vol $0.70 each |
86,000 | |
| Filed 2021-03-12 10:46 Tx date 2018-10-01 |
$LABS
MediPharm Labs Corp. |
McCutcheon, Patrick
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-03-12 10:45 Tx date 2021-03-05 |
$LABS
MediPharm Labs Corp. |
McCutcheon, Patrick
4 - Director of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$49,880
+86,000 vol $0.58 each |
1,354,000 | |
| Filed 2021-03-09 12:45 Tx date 2021-03-05 |
$LABS
MediPharm Labs Corp. |
McDonald, Miriam
4 - Director of Issuer
Direct Ownership
|
Warrants
15 - Acquisition or disposition under a prospectus
|
$11,900
+17,000 vol $0.70 each |
17,000 | |
| Filed 2021-03-09 12:37 Tx date 2018-10-01 |
$LABS
MediPharm Labs Corp. |
McDonald, Miriam
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-03-09 12:34 Tx date 2021-03-05 |
$LABS
MediPharm Labs Corp. |
McDonald, Miriam
4 - Director of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$9,860
+17,000 vol $0.58 each |
101,537 | |
| Filed 2021-03-08 15:32 Tx date 2021-03-05 |
$LABS
MediPharm Labs Corp. |
Halyk, Christopher John
4 - Director of Issuer
Direct Ownership
|
Warrants
15 - Acquisition or disposition under a prospectus
|
$60,199
+86,000 vol $0.70 each |
86,000 | |
| Filed 2021-03-08 15:31 Tx date 2020-08-04 |
$LABS
MediPharm Labs Corp. |
Halyk, Christopher John
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-03-08 15:31 Tx date 2021-03-05 |
$LABS
MediPharm Labs Corp. |
Halyk, Christopher John
4 - Director of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$49,880
+86,000 vol $0.58 each |
86,000 | |
| Filed 2021-03-08 15:30 Tx date 2020-08-04 |
$LABS
MediPharm Labs Corp. |
Halyk, Christopher John
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-03-08 15:03 Tx date 2021-03-05 |
$LABS
MediPharm Labs Corp. |
Taves, Christopher David
4 - Director of Issuer
Direct Ownership
|
Warrants
15 - Acquisition or disposition under a prospectus
|
$241,499
+345,000 vol $0.70 each |
345,000 | |
| Filed 2021-03-08 15:02 Tx date 2020-07-13 |
$LABS
MediPharm Labs Corp. |
Taves, Christopher David
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-03-08 15:02 Tx date 2021-03-05 |
$LABS
MediPharm Labs Corp. |
Taves, Christopher David
4 - Director of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$200,100
+345,000 vol $0.58 each |
345,000 | |
| Filed 2021-03-08 15:01 Tx date 2020-07-13 |
$LABS
MediPharm Labs Corp. |
Taves, Christopher David
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-03-05 14:54 Tx date 2021-03-05 |
$LABS
MediPharm Labs Corp. |
Tam, Paul Yiu Wing
4 - Director of Issuer
Direct Ownership
|
Warrants
15 - Acquisition or disposition under a prospectus
|
$120,399
+172,000 vol $0.70 each |
172,000 | |
| Filed 2021-03-05 14:51 Tx date 2019-04-30 |
$LABS
MediPharm Labs Corp. |
Tam, Paul Yiu Wing
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-03-05 14:50 Tx date 2021-03-05 |
$LABS
MediPharm Labs Corp. |
Tam, Paul Yiu Wing
4 - Director of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$99,760
+172,000 vol $0.58 each |
172,000 | |
| Filed 2021-03-05 14:49 Tx date 2019-04-30 |
$LABS
MediPharm Labs Corp. |
Tam, Paul Yiu Wing
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-03-05 14:48 Tx date 2019-04-30 |
$LABS
MediPharm Labs Corp. |
Tam, Paul Yiu Wing
4 - Director of Issuer
Direct Ownership
|
Units (Comprised of one share and one share purchase warrant)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-03-05 14:48 Tx date 2021-03-05 |
$LABS
MediPharm Labs Corp. |
Tam, Paul Yiu Wing
4 - Director of Issuer
Direct Ownership
|
Units (Comprised of one share and one share purchase warrant)
15 - Acquisition or disposition under a prospectus
|
$99,760
+172,000 vol $0.58 each |
||
| Filed 2021-03-05 14:23 Tx date 2021-03-05 |
$LABS
MediPharm Labs Corp. |
Tam, Paul Yiu Wing
4 - Director of Issuer
Direct Ownership
|
Units (Comprised of one share and one share purchase warrant)
15 - Acquisition or disposition under a prospectus
|
$99,760
+172,000 vol $0.58 each |
||
| Filed 2021-03-05 14:19 Tx date 2019-04-30 |
$LABS
MediPharm Labs Corp. |
Tam, Paul Yiu Wing
4 - Director of Issuer
Direct Ownership
|
Units (Comprised of one share and one share purchase warrant)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-03-05 14:18 Tx date 2019-04-30 |
$LABS
MediPharm Labs Corp. |
Tam, Paul Yiu Wing
4 - Director of Issuer
Direct Ownership
|
Units (Comprised of one share and one share purchase warrant)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-02-12 15:51 Tx date 2021-02-08 |
$LABS
MediPharm Labs Corp. |
Hunter, Gregory Edison
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
120,000 | ||
| Filed 2021-01-15 16:24 Tx date 2021-01-13 |
$LABS
MediPharm Labs Corp. |
Taylor, Sybil
5 - Senior Officer of Issuer
Direct Ownership
|
Options
38 - Redemption, retraction, cancellation, repurchase
|
-400,000 vol |
0 | |
| Filed 2020-12-11 12:21 Tx date 2020-10-19 |
$LABS
MediPharm Labs Corp. (formerly POCML 4 Inc.) |
Taylor, Sybil
5 - Senior Officer of Issuer
Direct Ownership
|
Options
38 - Redemption, retraction, cancellation, repurchase
|
-100,000 vol |
400,000 | |
| Filed 2020-12-11 12:09 Tx date 2020-12-08 |
$LABS
MediPharm Labs Corp. (formerly POCML 4 Inc.) |
Utkutug, Olga Seden
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
120,000 | ||
| Filed 2020-12-11 12:07 Tx date 2020-11-27 |
$LABS
MediPharm Labs Corp. (formerly POCML 4 Inc.) |
Kwon, Robert Hyok-Chin
5 - Senior Officer of Issuer
Direct Ownership
|
Options
38 - Redemption, retraction, cancellation, repurchase
|
-240,000 vol |
360,000 | |
| Filed 2020-11-03 16:33 Tx date 2020-10-08 |
$LABS
MediPharm Labs Corp. (formerly POCML 4 Inc.) |
Everitt, Warren
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$1,999,999
+2,359,603 vol $0.85 each |
2,386,553 | |
| Filed 2020-08-05 15:40 Tx date 2020-08-04 |
$LABS
MediPharm Labs Corp. (formerly POCML 4 Inc.) |
Halyk, Christopher John
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
300,000 | ||
| Filed 2020-07-21 12:42 Tx date 2020-07-13 |
$LABS
MediPharm Labs Corp. (formerly POCML 4 Inc.) |
Taves, Christopher David
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
300,000 | ||
| Filed 2020-06-23 16:52 Tx date 2020-06-22 |
$LABS
MediPharm Labs Corp. (formerly POCML 4 Inc.) |
Martin, Shelley
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
300,000 | ||
| Filed 2019-12-19 18:13 Tx date 2019-12-10 |
$LABS
MediPharm Labs Corp. (formerly POCML 4 Inc.) |
Taylor, Sybil
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-22,914
-6,700 vol $3.42 each |
159,767 | |
| Filed 2019-11-26 14:32 Tx date 2019-11-21 |
$LABS
MediPharm Labs Corp. (formerly POCML 4 Inc.) |
Taylor, Sybil
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-42,500
-10,000 vol $4.25 each |
166,467 | |
| Filed 2019-11-22 13:26 Tx date 2019-11-18 |
$LABS
MediPharm Labs Corp. (formerly POCML 4 Inc.) |
Kwon, Robert Hyok-Chin
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
600,000 | ||
| Filed 2019-11-22 13:25 Tx date 2019-11-18 |
$LABS
MediPharm Labs Corp. (formerly POCML 4 Inc.) |
Kwon, Robert Hyok-Chin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
4,100 | ||
| Filed 2019-11-21 17:01 Tx date 2018-10-01 |
$LABS
MediPharm Labs Corp. (formerly POCML 4 Inc.) |
Everitt, Warren
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
26,950 | ||
| Filed 2019-11-21 16:52 Tx date 2018-10-01 |
$LABS
MediPharm Labs Corp. (formerly POCML 4 Inc.) |
Everitt, Warren
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
150,000 | ||
| Filed 2019-11-18 12:18 Tx date 2019-11-14 |
$LABS
MediPharm Labs Corp. (formerly POCML 4 Inc.) |
Taylor, Sybil
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
$70,586
+58,822 vol $1.20 each |
176,467 | |
| Filed 2019-11-18 12:17 Tx date 2019-11-14 |
$LABS
MediPharm Labs Corp. (formerly POCML 4 Inc.) |
Taylor, Sybil
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
$-70,586.40
-58,822 vol $1.20 each |
0 | |
| Filed 2019-08-28 15:00 Tx date 2019-04-03 |
$LABS
MediPharm Labs Corp. (formerly POCML 4 Inc.) |
Taylor, Sybil
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
117,645 | ||
| Filed 2019-08-28 14:50 Tx date 2019-04-03 |
$LABS
MediPharm Labs Corp. (formerly POCML 4 Inc.) |
Taylor, Sybil
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
58,822 | ||
| Filed 2019-08-28 14:48 Tx date 2019-04-03 |
$LABS
MediPharm Labs Corp. (formerly POCML 4 Inc.) |
Taylor, Sybil
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
500,000 | ||
| Filed 2019-08-28 14:39 Tx date 2019-04-03 |
$LABS
MediPharm Labs Corp. (formerly POCML 4 Inc.) |
Taylor, Sybil
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-08-28 14:39 Tx date 2019-04-03 |
$LABS
MediPharm Labs Corp. (formerly POCML 4 Inc.) |
Taylor, Sybil
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
117,647 | ||
| Filed 2019-08-15 15:55 Tx date 2019-04-30 |
$LABS
MediPharm Labs Corp. (formerly POCML 4 Inc.) |
Tam, Paul Yiu Wing
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-08-15 15:39 Tx date 2019-04-30 |
$LABS
MediPharm Labs Corp. (formerly POCML 4 Inc.) |
Tam, Paul Yiu Wing
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-08-15 15:23 Tx date 2019-04-30 |
$LABS
MediPharm Labs Corp. (formerly POCML 4 Inc.) |
Tam, Paul Yiu Wing
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-08-15 15:22 Tx date 2019-08-13 |
$LABS
MediPharm Labs Corp. (formerly POCML 4 Inc.) |
Tam, Paul Yiu Wing
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,941,000
+300,000 vol $6.47 each |
300,000 | |
| Filed 2019-08-15 15:14 Tx date 2019-04-30 |
$LABS
MediPharm Labs Corp. (formerly POCML 4 Inc.) |
Tam, Paul Yiu Wing
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-06-24 07:55 Tx date 2019-06-20 |
$LABS
MediPharm Labs Corp. (formerly POCML 4 Inc.) |
Fenske, Braden William
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,600
+2,000 vol $4.80 each |
11,009 | |
| Filed 2019-06-21 08:32 Tx date 2019-06-17 |
$LABS
MediPharm Labs Corp. (formerly POCML 4 Inc.) |
Fenske, Braden William
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$48,828
+9,009 vol $5.42 each |
9,009 | |
| Filed 2019-06-20 09:06 Tx date 2019-04-29 |
$LABS
MediPharm Labs Corp. (formerly POCML 4 Inc.) |
Fenske, Braden William
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-05-03 10:31 Tx date 2019-04-29 |
$LABS
MediPharm Labs Corp. (formerly POCML 4 Inc.) |
Fenske, Braden William
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
500,000 | ||
| Filed 2019-04-05 10:13 Tx date 2019-03-29 |
$LABS
MediPharm Labs Corp. (formerly POCML 4 Inc.) |
Hobbs, Christopher
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$74,812
+317,000 vol $0.236 each |
634,000 | |
| Filed 2019-04-05 10:12 Tx date 2019-03-29 |
$LABS
MediPharm Labs Corp. (formerly POCML 4 Inc.) |
Hobbs, Christopher
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-74,812
-317,000 vol $0.236 each |
400,000 | |
| Filed 2019-04-05 10:10 Tx date 2019-04-04 |
$LABS
MediPharm Labs Corp. (formerly POCML 4 Inc.) |
Hobbs, Christopher
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-74,812
-317,000 vol $0.236 each |
||
| Filed 2019-01-18 Tx date 2018-11-05 |
$LABS
MediPharm Labs Corp. (formerly POCML 4 Inc.) |
Mayers, David John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$49,856
+32,800 vol $1.52 each |
32,800 | |
| Filed 2019-01-18 Tx date 2018-10-04 |
$LABS
MediPharm Labs Corp. (formerly POCML 4 Inc.) |
Mayers, David John
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-01-18 Tx date 2018-10-04 |
$LABS
MediPharm Labs Corp. (formerly POCML 4 Inc.) |
Mayers, David John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-01-18 Tx date 2019-01-08 |
$LABS
MediPharm Labs Corp. (formerly POCML 4 Inc.) |
Mayers, David John
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+70,000 vol |
550,000 | |
| Filed 2019-01-18 Tx date 2018-10-24 |
$LABS
MediPharm Labs Corp. (formerly POCML 4 Inc.) |
Mayers, David John
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+480,000 vol |
480,000 | |
| Filed 2019-01-18 Tx date 2018-11-05 |
$LABS
MediPharm Labs Corp. (formerly POCML 4 Inc.) |
Mayers, David John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,300
+2,200 vol $1.50 each |
37,090 | |
| Filed 2019-01-18 Tx date 2018-11-05 |
$LABS
MediPharm Labs Corp. (formerly POCML 4 Inc.) |
Mayers, David John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,155
+2,090 vol $1.51 each |
34,890 | |
| Filed 2019-01-14 Tx date 2018-10-01 |
$LABS
MediPharm Labs Corp. (formerly POCML 4 Inc.) |
Strachan, Keith
4 - Director of Issuer
Holder: Strachan Family Trust (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
6,340,000 | ||
| Filed 2019-01-14 Tx date 2019-01-08 |
$LABS
MediPharm Labs Corp. (formerly POCML 4 Inc.) |
McDonald, Miriam
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$240,000
+120,000 vol $2.00 each |
300,000 | |
| Filed 2019-01-14 Tx date 2019-01-08 |
$LABS
MediPharm Labs Corp. (formerly POCML 4 Inc.) |
McCutcheon, Patrick
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,300,000
+650,000 vol $2.00 each |
650,000 | |
| Filed 2019-01-14 Tx date 2019-01-08 |
$LABS
MediPharm Labs Corp. (formerly POCML 4 Inc.) |
McCutcheon, Patrick
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$300,008
+1,268,000 vol $0.2366 each |
1,268,000 | |
| Filed 2019-01-14 Tx date 2018-10-01 |
$LABS
MediPharm Labs Corp. (formerly POCML 4 Inc.) |
McCutcheon, Patrick
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-01-14 Tx date 2019-01-07 |
$LABS
MediPharm Labs Corp. (formerly POCML 4 Inc.) |
Strachan, Keith
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-270,007.92
-1,141,200 vol $0.2366 each |
0 | |
| Filed 2019-01-14 Tx date 2018-10-01 |
$LABS
MediPharm Labs Corp. (formerly POCML 4 Inc.) |
Strachan, Keith
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-01-14 Tx date 2018-10-01 |
$LABS
MediPharm Labs Corp. (formerly POCML 4 Inc.) |
McCutcheon, Patrick
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-01-14 Tx date 2019-01-07 |
$LABS
MediPharm Labs Corp. (formerly POCML 4 Inc.) |
McCutcheon, Patrick
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-300,008.80
-1,268,000 vol $0.2366 each |
0 | |
| Filed 2019-01-14 Tx date 2019-01-07 |
$LABS
MediPharm Labs Corp. (formerly POCML 4 Inc.) |
Strachan, Keith
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$270,007
+1,141,200 vol $0.2366 each |
1,141,200 | |
| Filed 2019-01-14 Tx date 2018-10-01 |
$LABS
MediPharm Labs Corp. (formerly POCML 4 Inc.) |
Strachan, Keith
4 - Director of Issuer
Holder: Strachan Family Trust (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-01-14 Tx date 2019-01-08 |
$LABS
MediPharm Labs Corp. (formerly POCML 4 Inc.) |
Strachan, Keith
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,200,000
+600,000 vol $2.00 each |
600,000 | |
| Filed 2019-01-10 Tx date 2018-10-01 |
$LABS
MediPharm Labs Corp. (formerly POCML 4 Inc.) |
Hobbs, Christopher
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-01-10 Tx date 2019-01-07 |
$LABS
MediPharm Labs Corp. (formerly POCML 4 Inc.) |
Hobbs, Christopher
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$74,970
+317,000 vol $0.2365 each |
317,000 | |
| Filed 2019-01-10 Tx date 2019-01-08 |
$LABS
MediPharm Labs Corp. (formerly POCML 4 Inc.) |
Raza, Marufur Syed
1 - Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$240,000
+120,000 vol $2.00 each |
314,709 | |
| Filed 2019-01-10 Tx date 2019-01-07 |
$LABS
MediPharm Labs Corp. (formerly POCML 4 Inc.) |
Hobbs, Christopher
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-317,000 vol |
317,000 | |
| Filed 2019-01-10 Tx date 2019-01-08 |
$LABS
MediPharm Labs Corp. (formerly POCML 4 Inc.) |
Hobbs, Christopher
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$800,000
+400,000 vol $2.00 each |
717,000 | |
| Filed 2018-11-13 Tx date 2018-10-01 |
$LABS
MediPharm Labs Corp. (formerly POCML 4 Inc.) |
McDonald, Miriam
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
180,000 | ||
| Filed 2018-11-04 Tx date 2018-10-24 |
$LABS
MediPharm Labs Corp. (formerly POCML 4 Inc.) |
Raza, Marufur Syed
1 - Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+180,000 vol |
194,709 | |
| Filed 2018-11-04 Tx date 2018-10-01 |
$LABS
MediPharm Labs Corp. (formerly POCML 4 Inc.) |
Raza, Marufur Syed
1 - Issuer
Holder: Zambian Holdings Inc. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
85,210 | ||
| Filed 2018-11-04 Tx date 2018-10-01 |
$LABS
MediPharm Labs Corp. (formerly POCML 4 Inc.) |
Raza, Marufur Syed
1 - Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
29,418 | ||
| Filed 2018-11-04 Tx date 2018-10-01 |
$LABS
MediPharm Labs Corp. (formerly POCML 4 Inc.) |
Raza, Marufur Syed
1 - Issuer
Holder: Zambian Holdings Inc. (Indirect Ownership)
|
Options
00 - Opening Balance-Initial SEDI Report
|
85,210 | ||
| Filed 2018-11-04 Tx date 2018-10-01 |
$LABS
MediPharm Labs Corp. (formerly POCML 4 Inc.) |
Raza, Marufur Syed
1 - Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
14,709 | ||
| Filed 2018-10-31 Tx date 2018-10-01 |
$LABS
MediPharm Labs Corp. (formerly POCML 4 Inc.) |
McCutcheon, Patrick
4 - Director of Issuer
Holder: The McCutcheon Family Trust (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
8,065,240 | ||
| Filed 2018-10-31 Tx date 2018-10-01 |
$LABS
MediPharm Labs Corp. (formerly POCML 4 Inc.) |
Strachan, Keith
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
1,141,200 | ||
| Filed 2018-10-31 Tx date 2018-10-01 |
$LABS
MediPharm Labs Corp. (formerly POCML 4 Inc.) |
McCutcheon, Patrick
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
1,268,000 | ||
| Filed 2018-10-31 Tx date 2018-10-01 |
$LABS
MediPharm Labs Corp. (formerly POCML 4 Inc.) |
Strachan, Keith
4 - Director of Issuer
Holder: Strachan Family Trust (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
634,000 | ||
| Filed 2018-10-31 Tx date 2018-10-01 |
$LABS
MediPharm Labs Corp. (formerly POCML 4 Inc.) |
McDonald, Miriam
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
84,537 | ||
| Filed 2018-10-10 Tx date 2018-10-01 |
$LABS
MediPharm Labs Corp. (formerly POCML 4 Inc.) |
Hobbs, Christopher
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
634,000 |